email: ahessel (at) gmail (dot) com
Skype: search for "Andrew Hessel", ahessel (at) gmail (dot) com
factsheet: see PDF
I am a consultant and catalyst for open source biology, synthetic biology, the international Genetically Engineered Machines (iGEM) program, DIYbio and open innovation models. I am also faculty and co-chair of the biotechnology and bioinformatics track at the Singularity University, located at the NASA Ames campus, near Mountain View, California.
My overarching goal is to help people better understand life science and apply it to relevant global challenges.
Global Challenges according to Richard Smalley (prioritization his)
see source article here (pdf)
6. Terrorism and War
I believe that until human population stabilizes (10), and an economic system is adopted that does not require continual growth and instead works to raise living standards for all humans (5), the other challenges won't be solved. Education (8) may be the key to solving all the challenges.
Life science is the only technology that is intrinsically linked to all human activity by virtue that we are all alive. We must better learn to harness living systems to meet the needs of humanity or risk further isolation from the living world and nature. Living systems (or once-living systems) are harnessed to produce energy, clean water, foodstuffs, and structural materials. Collectively, humans are mismanaging these resources and disrupting and contaminating the environment, putting society at risk of famine and disease, pollution, and ecosystem destruction.
Interested in Genomics and don't know where to start?
Genomics is as complicated as you want it to be. Essentially DNA instructs cells to make things, including more of themselves. Everything else is a technical detail. Rather than teach endless reams of stuff, I ask young people or others starting out this:
Knowing that with DNA one can program any cellular component, or any organism in existence today, or has existed (eg. dinosaurs), and possibly new components or organisms that nature didn't select for, what do you want to create or do?
Business and Consulting Activities
Pink Army Cooperative (open source biotech)
I am a co-founder, along with Jayson Tymko and John Carlson, of the world's first cooperative biotechnology company, the Pink Army Cooperative. Open source biotechnology can move faster than big pharma and make personalized medicines affordable. Today you can order a personalized genetic screen for a few hundred dollars. In five years it should be possible to get custom-made personalized cancer treatments.
For more information, check out the Pink Army website.
Q Squared Consulting Inc.
My consulting work (and life) is managed through Q Squared, an Alberta-based consulting company, founded in 2009. Inquire for rates and availability.
I co-chair the Biotechnology and Bioinformatics track at the Singularity University (SU), an interdisciplinary university whose mission is to prepare leaders for accelerating technological change. See http://singularityu.org for more information.
2010 Speaking Engagements and Activities
Pink Army Cooperative, A drug company for everyone, Open Science Summit 2010, Berkeley, July 29-31
Intelligent Design: An introduction to synthetic biology, IDEO, Palo Alto, July 29
FBI-DIYbio Meeting, St. Regis Hotel, Washington DC, July 22
Singularity University Graduate Studies Program, NASA Ames Research Center, Moffett Field, June - August
Altered Carbon: Programming, processing, and economics. Humanity+ Summit, Harvard University, June 12-13
Biology: Faster, Better, Cheaper, University of Alabama, Huntsville, May 20
X Prize Foundation, Life Science Prize Final Development, May 13-17
MoMo (Mobile Monday) Amsterdam, March 28
Alberta SuperDesigner Workshop, Red Deer, March 25-26
TEDx Edmonton, March 13
X Prize Foundation, Life Science Prize Visioning, March 10
Singularity University Executive Program (Winter), February 26 - March 7
Sustainable Communities Working Group, Calgary, January 27-28
OSLI Communications Workshop, Calgary, January 18
TEDxSV, "The End of Cancer", Standford University, December 12
Alberta Association of Colleges and Technical Institutes, "Driving Innovation", Banff, Alberta December 10 H+ Summit, Irvine, California, December 5-6
Biomedical Engineering Distinguished Speakers Series, Energy & Environmental Engineering, University of Calgary, November 19, 2009
Singularity University Executive Program, November 6-15, 2009
The Drive to Innovate, Conoco-Phillips, Calgary, November 3, 2009
iGEM 2009, MIT, Cambridge, MA October 30 - November 2, 2009 (attending only)
BIL:PIL, Building a Drug Development Pipeline for Personalized, Open Source Therapies for Breast Cancer. San Diego, October 30, 2009
TEDMED, San Diego, Oct 27-30, 2009 (attend)
SENS4, Cambridge, UK, September 3-7, 2009
Swedish-American Life Science Summit, Bionetworking Sessions, Stockholm, Sweden August 19-21, 2009
Singularity University, Introduction to synthetic biology and applications, July 20-21, 2009
iGEM Ontario Regional, University of Waterloo, May 29, 2009
SciBarCamp 2009, Toronto, May 8-9, 2009
Oil Sands Leadership Initiative keynote and meeting, Calgary, April 15-16, 2009
2008 Talks, Conferences, Posters
Convergence 08, Panel Debate, Talk, November 15-16, 2008
iGEM Jamboree, MIT, Cambridge, MA, November 7-9, 2008 (Chairing iGEM Canada session)
Singularity Summit 2008, San Jose, CA, October 25, 2008 (attending)
UofC Engineering, Calgary, Sept 24, 2008 (Engineering Biology)
SciFoo, Mountain View, CA, August 8-10, 2008
BioBarCamp, Palo Alto, CA, August 6-7, 2008
Science Cafe, Telus World of Science and Alberta Ingenuity, Edmonton, May 6, 2008
Sanofi Aventis BioTalent Challenge Keynote, Calgary, April 23, 2008
Sanofi Aventis BioTalent Challenge Keynote, Edmonton, April 16, 2008
Civil Society Synthetic Biology Teach-In, Washington DC, April 14, 2008 PDF
TEC Edmonton, Open Source Therapeutics, round 2, March 31, 2008
TEC Edmonton, Open Source Therapeutics, March 19, 2008
Open Source Therapeutics. UofA Digital Biology Meeting, March 17, 2008
Southern Alberta Institute of Technology (SAIT), Overview of Synthetic Biology, February 2008.